Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/50553
Título: New insights into the structure-cytotoxicity relationship of spirostan saponins and related glycosides
Autores/as: Pérez-Labrada, Karell
Brouard Martín,Ignacio 
Estévez, Sara 
Marrero, María Teresa
Estevez, Francisco 
Bermejo, Jaime
Rivera, Daniel G.
Clasificación UNESCO: 32 Ciencias médicas
2403 Bioquímica
Palabras clave: Solanum Steroidal Glycosides
Diosgenyl Saponins
Hemolytic-Activity
Triterpenoid Saponins
Dioscin Derivatives, et al.
Fecha de publicación: 2012
Proyectos: Evaluación de Potenciales Compuestos Antileucémicos. 
Publicación seriada: Bioorganic and Medicinal Chemistry 
Resumen: A variety of spirostan saponins and related glycosides were synthesized and evaluated for their cytotoxicity against the human myeloid leukemia cell line (HL-60). A linear glycosylation strategy allowed for accessing a variety of functionalization patterns at both the spirostanic and the saccharide moieties, which provides new information regarding the structure-cytotoxicity relationship of this family of steroidal glycosides. Intriguing results were achieved with respect to hecogenyl and 5 alpha-hydroxy-laxogenyl beta-chacotriosides, turning out to be the former very cytotoxic and the latter no cytotoxic at all. Importantly, the partially pivaloylated beta-D-glucosides of 5 alpha-hydroxy-laxogenin were the most potent cytotoxic compounds among all tested glycosides. This comprises the first report on acylated spirostanyl glucosides displaying significant cytotoxicity, and therefore, it opens up new opportunities toward the development of saponin analogues as anticancer agents.
URI: http://hdl.handle.net/10553/50553
ISSN: 0968-0896
DOI: 10.1016/j.bmc.2012.02.026
Fuente: Bioorganic & Medicinal Chemistry[ISSN 0968-0896],v. 20 (8), p. 2690-2700
Colección:Artículos
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.